---
title: "Moderna slips as Citi cuts to sell on \"unjustifiable\" valuation"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300567530.md"
description: "Moderna shares slipped in premarket trading after Citi downgraded the stock from Neutral to Sell. Analyst Geoff Meacham cited an \"unjustifiable\" valuation despite a Phase 3 trial win for Moderna's personalized cancer therapy, intismeran autogene, developed with Merck."
datetime: "2026-09-30T11:51:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300567530.md)
  - [en](https://longbridge.com/en/news/300567530.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300567530.md)
generator: "portal-rs"
---

# Moderna slips as Citi cuts to sell on "unjustifiable" valuation

Moderna (MRNA) shares slipped in premarket trading on Wednesday after Citi downgraded the COVID-19 vaccine maker to Sell from Neutral, citing an "unjustifiable" valuation following a late-stage trial win for its personalized cancer shot, intismeran autogene, developed with Merck (MRK). Analyst Geoff Meacham noted that since the Phase 3 win in melan...

### Related Stocks

- [MRNA.US](https://longbridge.com/en/quote/MRNA.US.md)
- [MRNX.US](https://longbridge.com/en/quote/MRNX.US.md)
- [MRNY.US](https://longbridge.com/en/quote/MRNY.US.md)
- [C.US](https://longbridge.com/en/quote/C.US.md)
- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)

## Related News & Research

- [CPHI 2026: Moderna builds on its COVID-era manufacturing lessons](https://longbridge.com/en/news/301156866.md)
- [BUZZ-Moderna shares rally after addition to Nasdaq 100; BofA raises price objective](https://longbridge.com/en/news/301431093.md)
- [Learn Why The Bull Case For Moderna Stock Could Change Following COO Appointment](https://longbridge.com/en/news/301390603.md)
- [Moderna Stock Is Trending: What's Going On?](https://longbridge.com/en/news/300713446.md)
- [Tempus expands multi-year collaboration with Moderna, Merck on V940 melanoma vaccine commercialization support](https://longbridge.com/en/news/301144495.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**